Two decades of innovation reveal mixed findings for quality, cost, and utilization—and unclear ways to resolve. The results are in on the impact of value-based payments (VBP) and once again, they're ...

Forbes contributors publish independent expert analyses and insights. I write about business model strategy and execution across healthcare. For some time now, changes in the structure and dynamics of ...

What’s the best way to improve commercial performance? For biopharma companies, according to a report from Accenture, the answer is investment and innovation. In a five-year study of 15 drugmakers, ...

Biopharmaceutical companies are looking for go-to-market approaches that go beyond customer expectations. Starting with a revolutionized technology platform allows these organizations to create value ...

Developing alternative payment models for commercial populations in specialties such as oncology is rife with practical challenges. Leading payers and practices share lessons to date. Many payers and ...

Meta Platforms Inc. is planning to release a commercial version of its artificial intelligence model designed for commercial use, according to a report today from the Financial Times. Meta released ...